72.6 F
New York
Monday, May 17, 2021

Pintec [NASAQ: PT] Announces Acquisition of Jishengtai

Must read

Oaktree [NASDAQ: OCSL] Announces Pricing of Underwritten Public Offering

Oaktree Specialty Lending Corporation disclosed that it has set the price of an underwritten public offering of $350.0 million aggregate principal amount of...

Black.one Introduces Cryptocurrency Exchange Venture with $10B in Funding

Black.one has disclosed Tuesday that it has launched Bullish Global. Bullish Global is a subsidiary of Black.one. It is a new blockchain-based cryptocurrency exchange...

Pfizer-BioNTech COVID-19 Vaccine Gets FA Approval for Emergency Use in Adolescents

Pfizer Inc. and BioNTech SE disclosed that its COVID-19 vaccine has got the FDA approval for its COVID-19 vaccine. After the approval,...

Soliton [NASDAQ: SOLY] to be Acquired by Allergan Aesthetics

Soliton, Inc. disclosed Monday that it has inked an agreement with Allergen Aesthetics. As per the agreement, Allergen Aesthetics will buy Soliton. Allergen...

Pintec Technology Holdings Limited [NASDAQ: PT] revealed Monday that it has acquired the Shenzhen Jishengtai Technology Co. Ltd (JST). Both the firms have inked the acquisition agreement after that PT has acquired all the equity interest of JST.

Pintec disclosed that the buying of JST and RB will speed up the plan of PINTEC in changing its business by expanding its wealth management services. PINTEC has always been a data and technology propelled firm. Since its inception, its main focus is on serving business and financial partners. The mission of the firm corresponds with the success factors at JCT/RB as they service business customers via their patented online securities trading implementation.

Financial Detail of the Acquisition

PINTEC has confirmed that it has decided to grant certain Consideration Shares to the original shareholders of JST. This grant is the payment for the sale of JST’s equity interest. Furthermore, The Consideration Shares will include a fixed base of 38,098,200 shares. It also includes an extra 45,098,200 shares, which depends on downward correction based on specific performance target on RB.

Moreover, The Consideration Shares will be granted as an exception from the obligation to register under Section 5 of the Securities Act of 1933. The deal is dependent on the execution of the required business and other authorizations and traditional closing circumstances.

More articles

Latest article

Elon Musk’s SpaceX to Roll Out Dogecoin-Backed Satellite to the Moon in 2022

Elon Musk’s SpaceX has decided to recognize Dogecoin as payment to roll out its “DOGE-1 Mission to the Moon”. The mission is going to...

SBI CEO Yoshitaka Kitao Reveals Ripple to Go Public after its Legal Battle with the SEC is Over

CEO of Japanese financial services company SBI Holdings, Yoshitaka Kitao disclosed that Ripple has opted for an option to go public once its legal...

Coinbase Pro Announces it will be Listing Internet Computer’s ICP

Coinbase Pro cryptocurrency exchange has disclosed that it has decided to list ICP once it goes live. ICP is the governance token of the...

WISeKey [NASDAQ: WKEY] Gets Investment to finance its TrustNFT.IO NFT Platform

WISeKey International Holding AG disclosed Friday that it has inked a term-sheet to enter into an unsecured short-term loan and the issuance and...

Moderna [NASDAQ: MRNA] Inks Supply Agreement with Switzerland

Moderna, Inc. disclosed that it has inked a supply agreement on Thursday with the Swiss Federal Government. As per the agreement, Moderna Inc...

TeraBlock Will Have its Own BSCPad IDO Soon

TeraBlock which is a project making a platform for automated cryptocurrency portfolio management disclosed that it is preparing for an initial DEX offering (IDO)...

Why Chiasma [NASDAQ: CHMA] Stock is Skyrocketed?

Shares of Chiasma, Inc. surged 46.48% during the trading session of Wednesday. Chiasma has disclosed the financial results for the Q1 completed March...

NeoGenomics [NASDAQ: NEO] Announces Acquisition of Inivata Ltd

NeoGenomics, Inc. revealed Wednesday that it has decided to purchase Inivata Ltd. Inivata will grow into a liquid biopsy-centered division together with increasing...